GlobalData on MSN

BD secures FDA 510(k) clearance for EnCor EnCompass system

"BD secures FDA 510 (k) clearance for EnCor EnCompass system" was originally created and published by Hospital Management, a ...

BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S.
MassDevice

BD wins FDA nod for breast biopsy, tissue removal system

BD (NYSE: BDX) announced today that the FDA granted 510(k) clearance for its EnCore EnCompass breast biopsy and tissue ...

Becton, Dickinson Wins FDA Clearance For Next-Gen Breast Biopsy Device, Launch Set For 2026

The FDA clears Becton Dickinson's EnCor EnCompass breast biopsy system, with a U.S. launch planned for early 2026.

BD (Becton, Dickinson and Company): BD Receives FDA 510(k) Clearance for EnCor EnCompass Breast Biopsy and Tissue Removal System

State-of-the-art, multi-modality breast biopsy system slated to be in the market in early 2026 FRANKLIN LAKES, N.J., Jan. 15, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: ...